CardioVascular BioTherapeutics Inc
Company Description: Cardio Vascular Bio Therapeutics - CVBT is a biopharmaceutical company established to commercialize the breakthrough therapy developed by Dr. Thomas-Joseph Stegmann to treat coronary artery disease with a process known as angiogenesis. The treatment consists of injecting human growth factor near a blocked coronary artery which in turn, improves blood flow into the ischemic heart.
1635 Village Center Cir Ste 250 Las Vegas, NV 89134-0574
Technologies: CardioVascular BioTherapeutics Inc is using 3 Technologies.
Social Media: CardioVascular BioTherapeutics Inc has 2 social media shares and likes.
We have 6 emails for CardioVascular BioTherapeutics Inc.
Verified Contacts from
These are contacts we've discovered through publicly available sources and might be outdated.
Use our PerfectLink™ Contact Finder to verify contacts.
Sign up to get full access to all the cvbt.com emails we have.
Find emails for CardioVascular BioTherapeutics Inc executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Marketing Officer.
Note: Only company contact information will be added. To discover and add individual contacts to My Prospects, please click though to the Company Profile page.